Kaken Pharmaceutical Co's total assets for Q1 2026 were ¥176.34B, a decrease of -7.39% from the previous quarter. JP:4521 total liabilities were ¥28.89B for the fiscal quarter, a -23.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.